146 related articles for article (PubMed ID: 9042371)
1. Purification of enzymatically active kallikrein hK2 from human seminal plasma.
Frenette G; Deperthes D; Tremblay RR; Lazure C; Dubé JY
Biochim Biophys Acta; 1997 Feb; 1334(1):109-15. PubMed ID: 9042371
[TBL] [Abstract][Full Text] [Related]
2. Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors.
Mikolajczyk SD; Millar LS; Kumar A; Saedi MS
Prostate; 1998 Jan; 34(1):44-50. PubMed ID: 9428387
[TBL] [Abstract][Full Text] [Related]
3. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
Charlesworth MC; Young CY; Miller VM; Tindall DJ
J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
[TBL] [Abstract][Full Text] [Related]
4. alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein.
Heeb MJ; España F
Blood Cells Mol Dis; 1998 Dec; 24(4):412-9. PubMed ID: 9851894
[TBL] [Abstract][Full Text] [Related]
5. Purification and characterization of human kallikrein 11, a candidate prostate and ovarian cancer biomarker, from seminal plasma.
Luo LY; Shan SJ; Elliott MB; Soosaipillai A; Diamandis EP
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):742-50. PubMed ID: 16467084
[TBL] [Abstract][Full Text] [Related]
6. Structural investigation of the alpha-1-antichymotrypsin: prostate-specific antigen complex by comparative model building.
Villoutreix BO; Lilja H; Pettersson K; Lövgren T; Teleman O
Protein Sci; 1996 May; 5(5):836-51. PubMed ID: 8732755
[TBL] [Abstract][Full Text] [Related]
7. Isolation of prostatic kallikrein hK2, also known as hGK-1, in human seminal plasma.
Deperthes D; Chapdelaine P; Tremblay RR; Brunet C; Berton J; Hébert J; Lazure C; Dubé JY
Biochim Biophys Acta; 1995 Dec; 1245(3):311-6. PubMed ID: 8541306
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic action of human glandular kallikrein 2 (hK2). Substrate specificity and regulation by Zn2+ and extracellular protease inhibitors.
Lövgren J; Airas K; Lilja H
Eur J Biochem; 1999 Jun; 262(3):781-9. PubMed ID: 10411640
[TBL] [Abstract][Full Text] [Related]
9. Potential involvement of kallikrein hK2 in the hydrolysis of the human seminal vesicle proteins after ejaculation.
Deperthes D; Frenette G; Brillard-Bourdet M; Bourgeois L; Gauthier F; Tremblay RR; Dubé JY
J Androl; 1996; 17(6):659-65. PubMed ID: 9016396
[TBL] [Abstract][Full Text] [Related]
10. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
[TBL] [Abstract][Full Text] [Related]
11. Studies on plasma inhibitors of plasma kallikrein using chromogenic peptide substrate assays.
Gallimore MJ; Amundsen E; Larsbraaten M; Lyngaas K; Fareid E
Thromb Res; 1979; 16(5-6):695-703. PubMed ID: 93313
[No Abstract] [Full Text] [Related]
12. Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2.
Mikolajczyk SD; Millar LS; Marker KM; Grauer LS; Goel A; Cass MM; Kumar A; Saedi MS
Eur J Biochem; 1997 Jun; 246(2):440-6. PubMed ID: 9208936
[TBL] [Abstract][Full Text] [Related]
13. Simple purification procedure for human prostatic kallikrein hK2 in its active form.
Frenette G; Tremblay RR; Dubé JY
J Chromatogr B Biomed Sci Appl; 1998 Aug; 713(2):297-300. PubMed ID: 9746244
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors.
Christensson A; Laurell CB; Lilja H
Eur J Biochem; 1990 Dec; 194(3):755-63. PubMed ID: 1702714
[TBL] [Abstract][Full Text] [Related]
15. Serpin-derived peptide substrates for investigating the substrate specificity of human tissue kallikreins hK1 and hK2.
Bourgeois L; Brillard-Bourdet M; Deperthes D; Juliano MA; Juliano L; Tremblay RR; Dubé JY; Gauthier F
J Biol Chem; 1997 Nov; 272(47):29590-5. PubMed ID: 9368023
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of a human prostate-specific glandular kallikrein, hK2, in E. coli and generation of antibodies.
Saedi MS; Cass MM; Goel AS; Grauer L; Hogen KL; Okaneya T; Griffin BY; Klee GG; Young CY; Tindall DJ
Mol Cell Endocrinol; 1995 Apr; 109(2):237-41. PubMed ID: 7664987
[TBL] [Abstract][Full Text] [Related]
17. Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling.
Piironen T; Villoutreix BO; Becker C; Hollingsworth K; Vihinen M; Bridon D; Qiu X; Rapp J; Dowell B; Lövgren T; Pettersson K; Lilja H
Protein Sci; 1998 Feb; 7(2):259-69. PubMed ID: 9521101
[TBL] [Abstract][Full Text] [Related]
18. Complex formation between protein C inhibitor and prostate-specific antigen in vitro and in human semen.
Christensson A; Lilja H
Eur J Biochem; 1994 Feb; 220(1):45-53. PubMed ID: 7509746
[TBL] [Abstract][Full Text] [Related]
19. Contamination of purified prostate-specific antigen preparations by kallikrein hK2.
Frenette G; Gervais Y; Tremblay RR; Dubé JY
J Urol; 1998 Apr; 159(4):1375-8. PubMed ID: 9507887
[TBL] [Abstract][Full Text] [Related]
20. Identification of a new tissue-kallikrein-binding protein.
Chao J; Tillman DM; Wang MY; Margolius HS; Chao L
Biochem J; 1986 Oct; 239(2):325-31. PubMed ID: 3643793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
